Search

Your search keyword '"DRUG therapy for hyperlipidemia"' showing total 1,647 results

Search Constraints

Start Over You searched for: Descriptor "DRUG therapy for hyperlipidemia" Remove constraint Descriptor: "DRUG therapy for hyperlipidemia"
1,647 results on '"DRUG therapy for hyperlipidemia"'

Search Results

1. Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report.

2. Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib.

3. The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure.

4. Factors associated with development of retinopathy in patients with type 2 diabetes mellitus at onset and within three years after diagnosis.

5. Anti-hyperlipidemic effects of 500 mg spilanthol (SA3X) supplementation in people with dyslipidemia – a randomized, parallel-group placebo-controlled trial.

6. Initial non-adherence to lipid-lowering medication: a systematic literature review.

7. Lipid-lowering effects of gefarnate in statin-treated patients with residual hypertriglyceridemia: a randomized controlled study.

8. Effectiveness of desertliving cistanche in managing hyperlipidemic osteoporosis in ovariectomized rats through the PI3K/AKT signaling pathway.

9. Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis.

10. Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

11. Research on Hepatocyte Regulation of PCSK9-LDLR and Its Related Drug Targets.

12. Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost.

13. Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia.

14. Diagnosis and treatment of dyslipidemia in children and adolescents.

15. Patient versus physician preferences for lipid‐lowering drug therapy: A discrete choice experiment.

16. Nephroprotective Potential of Sphaeranthus indicus Linn Extract against Hyperglycemia and Dyslipidemia in Streptozotocin-Induced Diabetic Nephropathy.

17. Population Pharmacokinetics of Atorvastatin in High‐Altitude and Plain Patients with Hyperlipidemic.

18. First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults.

19. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.

20. Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3.

21. Predictors for large vessel recanalization before stroke thrombectomy: the HALT score.

22. Red Yeast Rice and Statin Therapy in Patients with Hypercholesterolemia and the Comorbidities: A Retrospective Cohort Study on Lipid-Lowering Effects and Cardiovascular Outcomes.

23. Evaluating Medication Day-Supply for Improving Adherence and Clinical Biomarkers of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein.

24. Web-Based Electronic Health Record Program: A Twelve-Month Evaluation on Pharmacist's Intervention in Medicare Part D Annual Comprehensive Medication Review.

25. Statins.

26. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition).

27. Revisiting the interconnection between lipids and vitamin K metabolism: insights from recent research and potential therapeutic implications: a review.

28. Lipid abnormalities in pediatric kidney transplant recipients on steroid withdrawal maintenance immunosuppression.

29. Lipemic Serum in a Child with New Onset Diabetes Mellitus Presenting in Severe Diabetic Ketoacidosis: A Case Report.

30. Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials.

31. Danlou Recipe promotes cholesterol efflux in macrophages RAW264.7 and reverses cholesterol transport in mice with hyperlipidemia induced by P407.

32. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.

33. Case Report: Lipemia Retinalis in a 15-Year-Old.

34. Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international study.

35. Pemafibrate Improves Alanine Aminotransferase Levels Independently of Its Lipid-Lowering Effect.

36. Soy Sauce Lowers Body Weight and Fat Mass in High-Fat Diet-Induced Obese Rats.

37. Tafolecimab: First Approval.

38. Mechanisms of weight-loss effect in obese mice by the endogenous cannabinoid receptor 2 agonist beta-caryophyllene.

39. The future of clinical lipidology in the UK.

40. Diabetic kidney disease – Part 2: Management.

41. Novel approaches to the management of hyperlipidaemia.

42. Myrtle Berries Seeds Prevent Dyslipidemia, Inflammation, and Excessive Cardiac Reactive Oxygen Species Production in Response to High-Fat Diet–Induced Obesity.

43. Effect of arum manis mango peel extract on cholesterol and triglyceride levels in dyslipidemic Sprague-Dawley rats.

44. Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention.

45. Efficacy of Pemafibrate Versus Fenofibrate Administration on Serum Lipid Levels in Patients with Dyslipidemia: Network Meta-Analysis and Systematic Review.

46. 2023 China Guidelines for Lipid Management.

47. Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2–5.

48. Genitourinary syndrome of menopause ... and other research.

49. Safety Evaluation of the Polyherbal Formulation NawaTab: Acute and Subacute Oral Toxicity Studies in Rats.

50. Duyun compound green tea extracts regulate bile acid metabolism on mice induced by high-fat diet.

Catalog

Books, media, physical & digital resources